Back to 
NATIXIS
NATIXIS
ALXNShowing 0 of 8 quarters
Position history for NATIXIS's holdings in ALEXION PHARMACEUTICALS INC
As of its Q2 2021 13F, Natixis held 1,339,811 shares of ALXN (Alexion Pharmaceuticals), worth $246.1M. Natixis' 13F filings listed ALXN from Q4 2020 to Q2 2021, 3 quarterly filings. ALXN was 1.1% of Natixis' reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ALXN: FMR LLC, STATE STREET CORP